IDO Recombinant Antibody [PD00-62] - Mouse IgG1 (Chimeric)
Rmb: 699 特惠 1500
Catalog# HA601632
IDO Recombinant Antibody [PD00-62] - Mouse IgG1 (Chimeric)
-
WB
-
IHC-P
-
Human
-
HA610430
不含抗保成分
-
unconjugated
概述
产品名称
IDO Recombinant Antibody [PD00-62] - Mouse IgG1 (Chimeric)
抗体类型
免疫原
Synthetic peptide derived from the C-terminus of human IDO-1 protein.
种属反应性
Human
验证应用
WB, IHC-P
靶点分子量
Predicted band size: 45 kDa
阳性对照
A549 treated with 50ng/mL lFN-gamma for 24 hours cell lysate.
偶联
unconjugated
克隆号
PD00-62
产品特性
形态
Liquid
浓度
存放说明
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
存储缓冲液
1*PBS (pH7.4), 0.1% BSA, 40% Glycerol, 0.2% Proclean 950.
纯化方式
Protein A affinity purified.
应用稀释度
-
WB
-
1:2,000
-
IHC-P
-
1:1,000
靶点
功能
Indoleamine 2,3-dioxygenase (IDO) is an IFN-γ inducible enzyme that catalyzes the degradation of the essential amino acid L-tryptophan to N-formylkynurenine. The gene encoding human IDO maps to chromosome 8p12-p11. IDO, also known as INDO, is an important modulator of immunological responses and protects allogeneic concepti from alloreactive maternal lymphocytes. IDO mediates an interesting inhibitory effect of HeLa cells co-cultured with human PBLs. The ILN-2-induced proliferation response of PBLs is diminished in the presence of HeLa cells while an IDO inhbitor negates this effect. Flow cytometric analysis indicates both mature and immature CD123-positive dentritic cells suppress T cell activity using IDO. IDO-transfected cells co-cultured with T cells reduces T cell proliferation. Additionally, adopted transfer of donor T cells reduces donor T cell numbers in IDO-transgenic mice. The pharmacological or genetic manipulation of IDO may be useful for supressing undesirable T cell response.
背景文献
1. Fujiwara Y et al. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. Cancer Treat Rev. 2022 Nov
2. Al-Zoubi RM et al. IDO and TDO inhibitors in cancer immunotherapy: mechanisms, clinical development, and future directions. Front Pharmacol. 2025 Sep
亚细胞定位
Cytoplasm, cytosol.
UNIPROT
别名
3-dioxygenase antibody
I23O1_HUMAN antibody
IDO 1 antibody
IDO antibody
IDO-1 antibody
IDO1 antibody
INDO antibody
indolamine 2,3 dioxygenase antibody
Indole 2 3 dioxygenase antibody
indoleamine 2 3 dioxygenase 1 antibody
展开图片
-
☑ Cell treatment (CT)
Western blot analysis of IDO on different lysates with Mouse anti-IDO antibody (HA601632) at 1/2,000 dilution.
Lane 1: A549 (Human lung adenocarcinoma cell) cell lysate
Lane 2: A549 treated with 50ng/mL lFN-gamma for 24 hours cell lysate
Lysates/proteins at 15 µg/Lane.
Exposure time: 3 minutes; ECL: K1801
Blocking: 5% NFDM/TBST, 1 hour at room temperature
Primary antibody: HA601632, 1/2,000 in primary antibody dilution buffer (K1803), overnight at 4 °C
Secondary antibody: Goat anti-Mouse IgG-HRP (HA1006), 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 45 kDa
Observed band size: 45 kDa -
Application: Immunohistochemistry (IHC-P)
Species: Human
Tissue: Tonsil
Sample: Paraffin-embedded section
Antigen retrieval: Heat-mediated, Tris-EDTA buffer (pH 9.0), 20 minutes at 95°C.
Wash buffer: 1× TBST
Endogenous peroxidase blocking: 3% H₂O₂, 10 minutes at room temperature.
Blocking: 1% BSA + 10% normal goat serum, 10 minutes at room temperature.
Primary antibody: HA601632, 1/1,000, 1 hour at room temperature.
Secondary antibody: HA1120, 20 minutes at room temperature. -
Application: Immunohistochemistry (IHC-P)
Species: Human
Tissue: Tonsil
Sample: Paraffin-embedded section
Antigen retrieval: Heat-mediated, Tris-EDTA buffer (pH 9.0), 20 minutes at 95°C.
Wash buffer: 1× TBST
Endogenous peroxidase blocking: 3% H₂O₂, 10 minutes at room temperature.
Blocking: 1% BSA + 10% normal goat serum, 10 minutes at room temperature.
Primary antibody: HA601632, 1/1,000, 1 hour at room temperature.
Secondary antibody: HA1120, 20 minutes at room temperature.
请注意: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
浙公网安备 33019202000643号